Foundation Fighting Blindness Announces Leadership Changes
ncarol.com/10178661

Jason Menzo named chief executive officer

Russell Kelley, PhD, MBA, appointed managing director of the RD Fund

Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company

COLUMBIA, Md., June 21, 2022 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022. Ben Yerxa, PhD, who has served as CEO of the Foundation since 2017, will be transitioning to assume the permanent CEO position for Opus Genetics, the first spin-off company internally conceived and launched by the RD Fund to further the Foundation's mission.

More on ncarol.com

• Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto
• Equipment Leases, Inc. Launches Updated Family Office Equipment Financing Page
• Tickets now available for October 3rd Awadagin Pratt concert at the Tryon Fine Arts Center
• The $5 Million Man Still Begging: Incumbent Jimmy Panetta Hits Up Voters for More Cash Despite Massive War Chest
• Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs

---

Show All News | Disclaimer | Report Violation